{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "7857500", "DateCompleted": {"Year": "1995", "Month": "03", "Day": "23"}, "DateRevised": {"Year": "2017", "Month": "02", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0891-9887", "JournalIssue": {"Volume": "7 Suppl 1", "PubDate": {"Year": "1994", "Month": "Oct"}}, "Title": "Journal of geriatric psychiatry and neurology", "ISOAbbreviation": "J Geriatr Psychiatry Neurol"}, "ArticleTitle": "Hypericum treatment of mild depressions with somatic symptoms.", "Pagination": {"StartPage": "S12", "EndPage": "S14", "MedlinePgn": "S12-4"}, "Abstract": {"AbstractText": ["In a randomized, placebo-controlled, double-blind study, 39 patients with depression with somatic symptoms were treated with hypericum extract LI 160. The therapy lasted for 4 weeks; the dosage was 300 mg three times daily. At the onset of the study as well as after 2 and 4 weeks, the following criteria were analyzed: HAMD, B-L, CGI, and vegetative symptoms. The results show a significant improvement in the active treatment group at the 5% level as compared to placebo. Seventy percent of the patients treated with LI 160 were free of symptoms after 4 weeks. Typical symptoms of the depression such as lack of activity, tiredness, fatigue, and disturbed sleep, were especially responsive. In no case were any undesirable side effects observed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lichtwer Pharma GmbH, Berlin, Germany."}], "LastName": "H\u00fcbner", "ForeName": "W D", "Initials": "WD"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lande", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Podzuweit", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Geriatr Psychiatry Neurol", "NlmUniqueID": "8805645", "ISSNLinking": "0891-9887"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Xanthenes"}, {"RegistryNumber": "5QD5427UN7", "NameOfSubstance": "Perylene"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["complications", "drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Perylene"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Psychometrics"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Xanthenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "10", "Day": "1"}, {"Year": "1994", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7857500", "10.1177/089198879400700105"]}}]}